Table 2 Risk factor management and cardiovascular diagnoses after pregnancy.
From: Cardiovascular risk factor assessment after pre-eclampsia in primary care
| Â | PE Group (n = 35) | Control Group (n = 150) | P |
|---|---|---|---|
Mean follow-up time (y) ± SD | 2.9 (1.9) | 2.5 (1.8) | 0.29†|
Blood pressure control | 20 (57.1) | 18 (12.0) | < 0.001§ |
   Frequency |  |  |  |
1 time | 5 (25.0) | 10 (55.6) | Â |
2 times | 3 (15.0) | 4 (22.2) | Â |
≥ 3 times | 13 (65.0) | 4 (22.2) |  |
   Indication |  |  |  |
PE/partus related | 14 (70.0) | 2 (11.8) | Â |
Hypertension | 6 (30.0) | 5 (29.4) | Â |
Complaints of vascular disease | 0 (0.0) | 5 (29.4) | Â |
Screening/control | 0 (0.0) | 5 (29.4) | Â |
   Timing |  |  |  |
0-4 wks | 7 (35.0) | 3 (16.7) | Â |
4-12 wks | 4 (15.0) | 0 (0.0) | Â |
12-26 wks | 5 (25.0) | 0 (0.0) | Â |
26-52 wks | 0 (0.0) | 0 (0.0) | Â |
≥ 52 wks | 5 (25.0) | 15 (83.3) |  |
Glucose control | 1 (3.0) | 5 (3.3) | 1.00‡ |
Cholesterol control | 3 (9.1) | 7 (4.7) | 0.39‡ |
Cardiovascular diagnoses | Â | Â | Â |
   Hypertension*> 3 months postpartum | 6/30**(20.0) | 0 (0.0) | < 0.001‡ |
   Hypercholesterolemia | 0 (0.0) | 1 (0.7) | 1.00‡ |
   Gestational hypertensive disorder | 2 (6.1) | 1 (0.7) | 0.08‡ |
   Cardio-/cerebrovascular disorder | 1 (3.0) | 3 (2.0) | 1.00‡ |